Table 3.
Pathologic findings after operation: Comparing MIE-Ivor Lewis and MIE-McKeown.
| Tumor specific variables | Group A (n = 200) | Group B (n = 51) | P |
|---|---|---|---|
| AJCC stage, n (%) | |||
| I | 20 (10.0) | 7 (13.7) | 0.451 |
| IIa | 53 (26.5) | 11 (21.6) | 0.590 |
| IIb | 48 (24.0) | 11 (21.6) | 0.854 |
| III | 99 (49.5) | 22 (43.1) | 0.437 |
| Squamous tumor type, n (%) | 170 (85.0) | 45 (88.2) | 0.659 |
| Adenocarcinoma tumor type, n (%) | 24 (12.0) | 4 (7.9) | 0.618 |
| Neuroendocrine carcinoma, n (%) | 4 (2.0) | 2 (3.9) | 0.605 |
| Melanoma, n (%) | 2 (1.0) | 0 (0) | 1.000 |
| Adequacy of cancer resection | |||
| Negative margins, n (%) | 190 (95.0) | 49 (96.1) | 0.496 |
| Lymph nodes harvested(n) | 19.5 ± 9.6 | 27.5 ± 10.1 | 0.031 |
| Lymph nodes metastasis rate, n (%) | 105 (52.5) | 24 (47.1) | 0.532 |
| Adjuvant chemotherapy n (%) | 80 (40.0) | 18 (35.3) | 0.562 |
AJCC, American Joint Committee on Cancer.